Nasdaq

GE HealthCare's Flyrcado Sets New Benchmark in Cardiac PET Imaging

GE HealthCare GEHC recently unveiled new advancements in precision cardiac care at the 2025 SNMMI annual meeting in New Orleans, with a spotlight on Flyrcado—its FDA-approved Positron Emission ...
Business Wire

Patients in the US undergo first doses of GE HealthCare’s new PET radiotracer, Flyrcado (flurpiridaz F 18) injection

ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) has delivered the first patient doses of Flyrcado™ (flurpiridaz F 18) injection, a first-of-its-kind unit dose positron emission ...

Reflecting On Healthcare Equipment and Supplies Stocks’ Q1 Earnings: GE HealthCare (NASDAQ:GEHC)

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how GE HealthCare (NASDAQ:GEHC) ...
Seeking Alpha

GE HealthCare Technologies Inc. (GEHC) Presents at Jefferies London Healthcare Conference 2025 Transcript

Thanks for joining us here at the Jefferies Global Healthcare Conference, the JPMorgan of the East. So I'm Matt Taylor, the U.S. Medical supplies and devices analyst here at Jefferies, and I'm joined ...
CNBC

We're hiking our GEHC price target, looking beyond a mixed quarter to next year's catalysts

GE Healthcare reported a mixed quarter before Wednesday's opening bell. While revenue slightly missed, an earnings beat along with a number of other positives pushed the stock higher. Revenue rose ...
CNBC

GE Healthcare has been an under-the-radar winner — and a new catalyst just arrived

GE Healthcare 's quiet outperformance is becoming harder to tune out — and its new drug used in radiology to improve the diagnosis of heart disease can help the Club stock make some more noise. In a ...